Supporting US public health experts

Autor: John M. Maraganore, Paul Hastings, Cedric Francois, Jeremy M Levin, Michelle McMurry-Heath, Ted W Love, Rachel King, Cosignatories, Ronald A. Cohen, John Crowley

Publikováno v: Nature Biotechnology

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2323e9511935a77acd97d3e626ea719
https://doi.org/10.1038/s41587-020-00767-6

US immigration order strikes against biotech

Autor: Robert Langer, John M. Maraganore, David P. Schenkein, Neil Warma, Chris Adams, Chip Clark, Mark Levin, William Rastetter, Bruce A Leicher, Nancy A Thornberry, Robert I Blum, Jonathan G Rosin, Kleanthis G Xanthopoulos, Timothy D. Harris, Jeff L Cleland, Robert Forrester, Nancy Simonian, Peter Barrett, Stephen Bloch, William J Rieflin, Brian M Gallagher, Lewis Rusty Williams, Doug Doerfler, Richard Ulevitch, David R. Liu, Andrew Levin, P. Grint, Nick J Simon, Pablo J Cagnoni, Daphne Zohar, Kush M Parmar, Guy Macdonald, Corey M McCann, Stelios Papadopoulos, Michael D Clayman, Diego Miralles, Paula Cobb, John Diekman, Jeremy M Levin, Amir Nashat, Samuel G Waksal, Rachel King, Sandford Sandy Zweifach, Gail J Maderis, Ankit Mahadevia, Heather Franklin, Cary G Pfeffer, Steven K Brauer, Akshay Vaishnaw, Clay B. Siegall, Howard Furst, Jonathan S Leff, William J Rutter, Dennis J. Purcell, Mary T Szela, J C Gutierrez-Ramos, Sean A McCarthy, Elizabeth Lr Donley, Yaron Werber, Doug E Williams, Christoph Westphal, Paul Sekhri, W Eddie Martucci, Jeb Keiper, John E Osborn, Simba Gill, Bassil Dahiyat, Steven H Holtzman, Annalisa Jenkins, Saurabh Saha, Matthew J. During, Camille Samuels, Mara G Aspinall, Chad Robins, Jason P Rhodes, Herve Hoppenot, Jeff Kaplan, Michael A Narachi, Amit Rakhit, Julia C Owens, Steve M Paul, Martin Varsavsky, Mark G. Currie, Rajeev Shah, Rob Perez, H. Stewart Parker, Jeff Stein, Leonard Patrick Gage, Perry Karsen, Joel F Martin, Bob More, Matthew Perry, James G McArthur, Gregory J Flesher, Martin Tolar, Andrew Schwab, James A Geraghty, Eric L Dobmeier, Brook Byers, Vanessa King, Mason W. Freeman, Larry Miller, Marco Taglietti, Jeff Albers, Neil A Exter, Michael W Bonney, Ron Cohen, Nick Leschly, Bruce L Booth, William J Newell, Peter Kolchinsky, Ryan J Watts, Paul Laikind, Andrew G. Myers, Cedric Francois, Stephen T Isaacs, Scott Koenig, Michel Vounatsos, Tuan Ha-Ngoc, Nicholas Galakatos, George P Vlasuk, Isaac Ciechanover, Jeff Kindler, Brian M. Cali, Matthew R Patterson, Kenneth I Moch, Tom Graney, Martin Babler, Jonathan J Fleming, Mark A Goldsmith, Daniel M Bradbury, John Mendlein, Mike Powell, Nessan Bermingham, Eric Elenko, H. Robert Horvitz, Yujiro Steve Hata, Mark Pruzanski, Faheem Hasnain, Henri A. Termeer, Maxine Gowen, Scott M Rocklage, Anne VanLent, Thomas Shenk, Leslie Henshaw, Jeff Jonker, Nina Kjellson, Deborah Dunsire, Zoe Barry, Ron C Renaud, Alex Martin, Uri Lopatin, George Scangos, Jean Kim, Kartik Ramamoorthi, Michael Rosenblatt, Nagesh K Mahanthappa, Harvey F. Lodish, Paul B Bolno, Wendell Wierenga, Atul Pande, Barry Greene, Alan Levy, Adrian Ad Rawcliffe, Wende S Hutton, C Geoffrey McDonough, Vicki L. Sato, Jean-Francois Formela, David V. Goeddel, Bill Haney, Rich Heyman, James E Audia, Ron Cooper, Nina Tandon, Brett Ahrens, Julian Adams, Peter Hecht, John J Lee, Stuart L. Schreiber, Laurence E Reid, Bernat Olle, Paul Hastings, John A. Scarlett, Michael Su, David Grayzel, Ted W Love, Arnold J. Levine, Gerhard Koenig, Thomas E Hughes, Jens W Eckstein, Wendy Nelson, Vikas Goyal

Publikováno v: Nature Biotechnology. 35:204-206

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee2d10770c0eb9d17bb770366663a693
https://doi.org/10.1038/nbt.3824

Accelerated approval of Oxbryta® (voxelotor): A case study on novel endpoint selection in sickle cell disease

Autor: Linda Yokoshima, Barbara Tong, Ted W. Love, Joshua Lehrer-Graiwer

Publikováno v: Contemporary Clinical Trials. 98:106161

Sickle cell disease (SCD) is an inherited disease characterized by hemolysis, anemia, and vaso-occlusion leading to substantial morbidity and mortality. Development of prior pharmacologic therapies exclusively utilized vaso-occlusive crisis (VOC) as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65a77f6fdf29c8e758af9e8858a371ab
https://doi.org/10.1016/j.cct.2020.106161

An angiographic assessment of alteplase: Double-bolus and front-loaded infusion regimens in myocardial infarction

Autor: Stephen R. McMechan, Ted W. Love, Stanley D. Bleich, A.A.J. Adgey

Publikováno v: American Heart Journal. 136:741-748

Background This study was designed to investigate the efficacy of alteplase double-bolus dosing compared with the front-loaded 90-minute infusion regimen in patients with acute myocardial infarction. Recent pilot studies have suggested that bolus dos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e63be724b78b4c9e5ce6fe562eac0ec7
https://doi.org/10.1016/s0002-8703(98)70024-9

Attachment of an antifibrin antibody to the amino terminus of tissue-type plasminogen activator impairs stimulation by Fibrin

Autor: K.D. Michelson, Marschall S. Runge, Edgar Haber, Ted W. Love, Thomas Quertermous, Gary R. Matsueda

Publikováno v: Fibrinolysis. 8:326-332

On evidence that the potency and specificity of tissue-type plasminogen activator (t-PA) can be improved by chemical conjugation to an antifibrin antibody (59D8), we constructed a recombinant molecule, 59D8-t-PA(AB), containing a truncated 59D8 antib

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3aa23cc1a7658f110315b664093cf9a3
https://doi.org/10.1016/0268-9499(94)90022-1